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Abstract
Background: Patients undergoing major cancer surgery frequently require post-acute care for complications and
adverse effects. Enhanced recovery after surgery programmes mean that patients are increasingly discharged home
earlier. Symptom/complication detection post-discharge is sub-optimal. Systematic patient monitoring post-discharge
following surgery may be optimally achieved through routine electronic patient-reported outcome (ePRO) data
capture. ePRO systems that employ clinical algorithms to guide management of patients and automatically alert
clinicians of clinically-concerning symptoms can improve patient outcomes and decrease hospital admissions. ePRO
systems that provide individually-tailored self-management advice and integrate live ePRO data into electronic health
records (EHR) may also advance personalised health and patient-centred care. This study aims to develop a hospital
EHR-integrated ePRO system to improve detection and management of complications post-discharge following
cancer-related surgery.
Methods: The ePRO system was developed in two phases: (1) Development of a web-based ePRO symptom-report
from validated European Organisation for Research and Treatment of Cancer (EORTC) questionnaires, clinical opinion
and patient interviews, followed by hospital EHR integration; (2) Development of clinical algorithms triggering
symptom severity-dependent patient advice and clinician alerts from: (i) prospectively-collected patient-
completed ePRO symptom-report data; (ii) stakeholder meetings; (iii) patient interviews. Patient advice was
developed from: (i) clinician-patient telephone consultations and patient interviews; (ii) review of hospital
patient information leaflets (PIL) and patient support websites.
Results: Phase 1, including interviews with 18 patients, identified 35 symptom-report items. In phase 2, 130/300
(43%) screened patients were eligible. 61 (47%) consented to participate and 59 (97%) provided 444 complete self-
reports. Stakeholder meetings (9 clinicians, 1 patient/public representative) and patient interviews (n = 66) refined
advice/alert accuracy. 15 telephone consultations, 7 patient interviews and review of 28 PILs and 3 patient support
websites identified 4 themes to inform self-management advice. Comparisons between ePRO symptom-report data,
telephone consultations and clinical events/outcomes (n = 27 patients) further refined clinical algorithms.
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Conclusions: A hospital EHR-integrated ePRO system that alerts clinicians and provides patient self-management
advice has been developed to improve the detection and management of problems and complications after
discharge following surgery. An ongoing pilot study will inform a multicentre randomised trial to evaluate the
effectiveness of the ePRO system compared to usual care.
Keywords: Adverse effects, Patient-reported outcome measures, Electronic, Electronic health records, Internet,
Neoplasms, Operative, Outcome assessment, patient, Self-management, Surgical procedures
Background
Surgery may cure or alleviate cancer but is associated
with significant complications and adverse effects (AEs).
Up to 30% of patients undergoing major abdominal surgery
for oesophageal cancer experience acute or long-term com-
plications, such as infection or the need for further inter-
vention [1], and as many as 45% of patients who have
undergone major cancer surgery require post-acute care,
such as hospital readmission or community care [2–5].
With more widespread implementation of enhanced recov-
ery after surgery (ERAS) programmes, patients are
discharged home increasingly earlier. Detection of compli-
cations once at home, however, requires patients to distin-
guish between symptoms that are typical of recovery (such
as expected levels of pain in the first few days) and those
that are clinically concerning (such as a change in or wors-
ening of pain). Uncertainty about the significance of symp-
toms and concerns about self-monitoring and self-care can
be worrying and burdensome for patients, their family and
caregivers [6], and can delay patients receiving treatment
[7–9]. Late detection and treatment of complications can
lead to poor patient outcomes [10], impaired quality of life
and increased emergency department admissions, with up
to 25% of patients being readmitted to hospital within 30
days of major cancer surgery [11, 12].
Prompt identification of complications and AEs after
patients are discharged from hospital following surgery
for cancer is critical to improve patient safety, outcomes
and experiences and enable healthcare professionals
(HCP) to plan appropriate care [13–17]. Telephone calls
from healthcare providers have been shown to effectively
reduce symptoms in cancer patients [18] but allocating
HCP time to make patient calls can be cost prohibitive
[19]. Instead, systematic monitoring may be optimally
achieved through the routine capture of electronic
patient-reported outcome data (ePRO), their automatic
scoring and the real-time communication of this data to
clinicians after hospital discharge. A systematic review of
24 controlled trials concluded that the routine use of
PRO measures (PROMs) enhances consultations and
may offer improved symptom control and patient
satisfaction [20]. However, only two of the 11 elec-
tronic systems included were delivered in the pa-
tients’ home setting.
Specific features of ePRO systems may provide added
benefit. Firstly, the use of clinical algorithms to evaluate
patient-reported symptom data and alert healthcare pro-
viders when severity reaches a pre-determined threshold
can help improve patient outcomes [15, 19]. Basch et al.
[15] conducted a large randomised controlled trial
(RCT) comparing a web-based Symptom Tracking and
Reporting (STAR) ePRO system versus usual care in 766
patients receiving chemotherapy for metastatic solid tu-
mours in the United States, in which severe or worsen-
ing symptoms triggered an email alert to a clinical nurse.
Findings indicated that the routine and real-time report-
ing of PROs during cancer surveillance can reduce hos-
pital readmissions and improve patients’ survival and
health-related quality of life (HRQL) measured using the
EuroQol EQ-5D Index [15]. This study was, however,
conducted in a single tertiary referral centre, limiting its
generalisability and HRQL was not assessed at follow-up
for nearly a third of patients due to attrition resulting
from death or discontinuation of treatment. Further-
more, use of a generic PROM measuring only broad
aspects of health did not provide insight into the ex-
tent to which specific symptoms were improved by
symptom reporting.
Patient safety and care may be further enhanced if
ePRO are embedded within systems with the functional-
ity to provide patients with individually-tailored advice
to support at-home symptom self-management [21]. In a
multicentre placebo-controlled RCT of 173 patients con-
ducted in the Netherlands, van der Meij et al. showed
how an eHealth intervention that included personalised
advice promoted a faster return to normal activities
compared to usual care for patients undergoing surgery
for benign conditions [22]. Provision of tailored advice
is, however, not a common feature of ePRO systems,
with many generating PROM data only for clinician re-
view [20, 23]. Finally, making routinely collected ePRO
data available to clinicians through its integration into
patients’ electronic health records (EHR) has the poten-
tial to advance precision health and patient-centred care
[24] by enabling ePRO data to be considered alongside
other clinical data to better plan appropriate care, to in-
form patient-clinician encounters and to improve shared
clinical decision-making [25]. Integration of ePRO data
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into patients’ EHR is, however, rare, likely because it is
challenging, requiring resources, familiarisation and syn-
chronisation with local information technology (IT) sys-
tems, adherence to data security regulations and user
training [20, 25].
Several of the ePRO systems developed to date are
intended for the oncology setting [26–28]. Most, how-
ever, are targeted to patients undergoing chemotherapy,
including the STAR system for patients with breast, gen-
itourinary, gynaecological or lung cancer in the US [26]
and the ASyMS system for patients with lung, breast
and colorectal cancer in the UK [27]. Comparably, few
ePRO systems have been developed specifically for pa-
tients undergoing surgery for cancer. SIS.NET, for ex-
ample, is a web-based system developed in the US to
improve follow-up care in patients undergoing surgery,
radiotherapy, chemotherapy or experimental therapies
for breast cancer [28]. Patients randomised to SIS.NET
completed regular online health questionnaires with re-
mote review by a nurse practitioner and attended 3
clinic appointments over 18 months. Depending on pa-
tient responses, the questionnaire generated automated
referrals to support resources at a local cancer centre.
Findings from 102 patients showed that the system im-
proved the quality and efficiency of follow-up care, with
SIS.NET patients reporting more new or changed symp-
toms than patients receiving standard care. The symp-
tom questionnaire reports were not, however, integrated
within routine hospital EHR. The exact number of pa-
tients who received surgery is, also, unknown. To the
best of our knowledge, an ePRO system for patients
undergoing surgery for cancer with the functionality to
integrate with hospital EHR and apply clinical algo-
rithms to alert clinicians and provide individually-tai-
lored self-management advice to guide patient
management is lacking [19, 20, 29]. Here, we describe
the development of a hospital EHR-integrated ePRO sys-
tem to improve the detection of complications and AEs
after discharge following cancer-related surgery, illus-
trated in the first instance in the example context of
cancer-related major abdominal surgery.
Methods
ePRO platform
The platform used to develop the ePRO system was
adapted from the model developed for the eRAPID
(Electronic patient self-Reporting of Adverse-events: Pa-
tient Information and aDvice) study [30]. The eRAPID
IT platform developed at the University of Leeds as an
example of a ‘hybrid’ system involving a separate PRO
facility linking with an existing EHR. The IT elements,
developed in a previous eRAPID study [30] include a pa-
tient website (with secure login function), web-based
symptom-report questionnaire software (QTool) and a
web application interface for secure transfer of the pa-
tient data to EHR and viewing of the symptom-report by
clinicians. Algorithms can be programmed into the
self-report scoring (in QTool), allowing severity-specific
tailored self-management advice to be provided to pa-
tients and email notifications sent to allocated clinicians.
The system was initially developed for patients undergo-
ing systemic therapy and radiotherapy [30–32].
The surgical ePRO system was developed between
February 2014 and August 2017 in two phases (Figs. 1
and 2), including: (1) Development of the symptom-re-
port for the ePRO system along with necessary IT inte-
gration into hospital EHR, and; (2) Development of
clinical algorithms to trigger symptom severity-dependent
patient advice and clinician alerts based on ePRO self-re-
port responses. Input from key stakeholders, including pa-
tients and clinicians, was sought in both phases, as
described below.
Phase 1: symptom-report development and ePRO system
integration into hospital EHR (Fig. 1)
Step 1: selection of relevant ePRO symptom-report items
Items for inclusion in the ePRO symptom-report ques-
tionnaire were identified from a scoping review of exist-
ing established, validated European Organisation for
Research and Treatment of Cancer (EORTC) question-
naires. EORTC items were selected for their relevance to
symptoms and complications experienced by patients
after cancer-related major abdominal surgery, including
oesophageal, gastric and hepato-pancreato biliary (upper
gastrointestinal or UGI) cancer. In this context, UGI is
used as a fully inclusive term, to include hepato-pan-
creato biliary cancer. EORTC items were also selected
based on the familiarity of the measures to the clinical
and study teams and their established routine use in
international trials of PROMs to improve patient out-
comes and care [20]. Cognitive interviews with patients
with experience of undergoing major UGI surgery were
performed to evaluate the acceptability and suitability of
the scope of selected items. Between November 2013
and May 2014, inpatient and outpatient lists at Univer-
sity Hospitals Bristol NHS Foundation Trust (UHBT)
were screened by a research nurse to identify potentially
eligible participants aged 18 or over who had undergone
cancer-related major abdominal surgery, including sur-
gery for oesophageal, gastric or hepato-pancreato biliary
cancer. Eligible patients were purposively sampled to en-
sure the inclusion of a wide range of patients. The re-
searcher explained the study and provided the patient
with a participant information sheet. The patient was
given time to read through the information and ask
questions before confirming whether they wished to par-
ticipate in the study and providing written informed
consent. For those patients who expressed an interest in
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participating, the researcher scheduled a convenient
time to conduct the interview either by telephone or
face-to-face at the hospital or in the patient’s home.
Cognitive interviews were conducted by a researcher to
determine participant’s comprehension of the self-report
items. Verbal probes were used to investigate partici-
pants’ thought processes while responding to items, and
participants were encouraged to indicate any trouble un-
derstanding or answering items. This work was con-
ducted in iterative cycles of sampling and data analyses
to refine the selection of items.
Step 2: patient care pathway analysis
Analysis of the care pathway for patients undergoing
major UGI surgery at a single UK hospital trust
(University Hospitals Bristol NHS Foundation Trust,
UHBT) was undertaken by study researchers (EOCF,
KA) and the cancer nurse specialist team (JB, TR) to
determine relevant clinician points of contact and
appropriate timepoints for ePRO self-report comple-
tion by patients during their recovery post-discharge
following surgery.
Step 3: integration of the ePRO system into hospital
electronic health records
To facilitate the integration of the ePRO system into the
existing hospital EHR system at UHBT (Medway,
SystemC), several meetings were held between the
study team, the University of Leeds IT team and the
UHBT IT team between March 2015 and January
2016. Analysis of IT system performance and integration
(e.g. downtime) was undertaken to monitor any issues re-
lated to integration.
Phase 2: development and testing of clinical algorithms
to guide patient management by symptom severity (Fig. 2)
Phase 2 of the study was conducted in three steps.
Fig. 1 Phase 1: Symptom-report development and ePRO system integration into hospital electronic health records
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Step 1: development of clinical algorithms
Informed by previous research undertaken to develop
the eRAPID systems in Leeds and Manchester [32]; [31],
it was decided a priori that clinical algorithms would
stratify patients into three levels of symptom severity
based on their completed ePRO symptom-reports, each
triggering a different ‘level’ of action within the ePRO
system (Table 1). In addition, so that patients reporting
multiple symptoms were not over-burdened with
self-management advice, advice was provided for a max-
imum of the six most clinically concerning symptoms
per ePRO self-report completion. To achieve this, four
clinicians responsible for the clinical care of patients
undergoing major UGI surgery ranked symptoms mea-
sured by the ePRO self-report in order of clinical
importance. A similar approach has been used in the
eRAPID study [30].
Clinical algorithms to guide severity-specific tailored pa-
tient self-management advice based on patient-reported
symptoms were developed using four data sources (Fig. 2).
Between 15/04/2016 and 15/08/2017, all consecutive pa-
tients being discharged from UHBT following cancer-re-
lated major abdominal surgery were screened for study
eligibility by a cancer nurse specialist at the point of dis-
charge (e.g. immediately preceding or on the day of dis-
charge). Patients were considered eligible to enter the
study if they met all the following inclusion criteria: (i)
undergone cancer-related major abdominal surgery
(including surgery for oesophageal, gastric or hepato-pan-
creato biliary cancer); (ii) ready for hospital discharge to
their home; (iii) have access to personal computer/tablet
and internet from home; (iii) sufficient capacity and un-
derstanding of English; (iv) aged 18 or over; (v) able to ad-
here to the study follow-up schedule. Eligible patients
were provided with a participant information leaflet
explaining the purpose and details of the study when ap-
proaching the point of discharge (e.g. on the inpatient
ward prior to discharge) and given the opportunity to ask
questions by the research nurse. Participants indicating
that they wished to participate were asked by the nurse to
provide written informed consent and baseline demo-
graphic and clinical details were recorded. On the day of
discharge, participants were given unique login details and
Fig. 2 Phase 2: Development and testing of clinical algorithms to guide patient management by symptom severity
Table 1 Guided management of patients by symptom severity
and ePRO system actions
Symptom severity level ePRO system action(s)
Level 1: expected symptom(s) Patient advice: self-management advice
Level 2: potentially concerning
symptom(s)
Patient advice: contact a health care
professional today if symptom
is new or unreported
Level 3: symptom(s) indicative
of a complication
(i) Patient advice: contact a health care
professional immediately
(ii) Clinician alert: automated email to a
health care professional
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information about accessing the ePRO system via the
website on a study information card. A demonstration of
the ePRO system was also provided by the research nurse.
Following discharge, participants were requested to
prospectively complete the ePRO self-report at discharge
(baseline), twice in the first week (day 2 and day 7 ap-
proximately) and weekly thereafter for 8 weeks. One
email and/or text message reminder with a direct link to
the ePRO website was sent to participants on the days
they were due to complete the ePRO self-report. How-
ever, patients could choose to log in and complete the
self-report at any time during this period that they felt
unwell or wanted advice. Participants were also asked to
participate in a weekly telephone interview with a study
researcher/research nurse, in which they were asked to
reflect on the nature and severity of any symptoms they
had experienced during the previous week. In addition,
two stakeholder meetings with a patient and public rep-
resentative and clinicians responsible for the clinical care
of patients undergoing major UGI surgery were con-
ducted. Finally, end of study interviews with a subset of
approximately 10% of study participants were conducted
approximately 10 weeks post-discharge. Purposive sam-
pling was used to obtain a sample of participants with a
diverse range of post-operative experiences and who had
used the ePRO system to varying extents. Targeted ver-
batim transcription of interview audio-recordings was
undertaken [33], whereby only those interviews contain-
ing data relevant to the research questions were tran-
scribed for analysis (i.e. if a participant’s completion of
the ePRO self-report had generated advice or feedback).
Data from the completed patient-completed ePRO
self-reports, weekly patient interviews, stakeholder meet-
ings and end of study patient interviews were considered
together. Data were prospectively analysed in an itera-
tive, cyclical manner as data collection and analyses pro-
ceeded to develop and refine the symptom severity
thresholds that would subsequently inform the develop-
ment of the clinical algorithms to trigger ePRO system
actions. The purpose of this was to identify and agree
upon symptoms and symptom severities associated with
a ‘typical’ recovery following surgery and those that
would be considered clinically concerning and to iden-
tify symptoms (and associated timepoints) for which ad-
vice or reassurance would have been beneficial. These
data were used to further refine the selection of items
included in the developmental version of the ePRO
self-report questionnaire (described above).
Step 2: development of patient self-management advice
Patient self-management advice was developed using
three data sources. Data were collated from, firstly,
audio-recordings of end-of-study interviews (described
above) and, secondly, telephone-based clinical consultations
undertaken in the first week post-discharge (typically on or
around days 2 and 7 post-discharge) between a UHBT can-
cer nurse specialist (CNS) and participants as part of usual
care. These consultations were audio-recorded to explore
any advice and/or reassurance offered by the CNS to pa-
tients. Targeted verbatim transcription of audio-recordings
was undertaken, and data analysed to identify themes relat-
ing to post-operative advice and reassurance and consider
appropriate phrasing and terminology to inform the devel-
opment of the ePRO system self-management advice. Be-
tween September 2016 and January 2017, a scoping search
of online patient information/advice and literature provided
by or recommended by the UK National Health Service
(NHS) Trusts in England (e.g. on NHS Trust websites or
NHS Trust recommended websites such as Macmillan
Cancer Support) was undertaken. Search terms specific to
patient information and advice (e.g. ‘patient information
leaflet’) and relevant surgical procedures (e.g. ‘oesophagect-
omy’) were used. Information/literature was excluded if it
did not relate to relevant procedures or was not from an
NHS-approved source. Relevant themes and terminology
were extracted from included information/literature using a
content analysis approach and used, alongside data from
the telephone consultations (described above), to draft the
ePRO system patient self-management advice, in accord-
ance with the three pre-determined symptom severity levels
described above (Table 1). The draft advice was iteratively
refined through discussion within the study group and with
clinicians involved in the stakeholder meetings until discus-
sions confirmed that no further iterations were required.
Step 3: testing and refinement of clinical algorithms
Data previously generated from a subset of participants’
earlier in Phase 2 of the study (described above) who re-
ported clinically-significant symptoms were reviewed
and used to test and refine the clinical algorithms.
Participants included in the subset were those who had
reported symptoms of a severity that would trigger ac-
tions by the ePRO system (i.e. a Level 1, 2 or 3 action).
Actions triggered by the ePRO system and the content
of any patient self-management advice provided as part
of those actions were compared, firstly, with the patient
advice provided by the CNS or study research nurse during
the routine telephone consultations and weekly telephone
interviews and, secondly, with any subsequent clinical
events or outcomes of participants (e.g. such as re-interven-
tion, re-admission to hospital, visit to GP or primary health-
care providers). The latter were identified from hospital
readmission alerts, hospital EHR, and patients’ reports of
accessing healthcare services reported during weekly
follow-up telephone interviews. Any discrepancies between
actions triggered by the ePRO system and advice provided
by the nurses were discussed within the study team. Where
considered necessary, the clinical algorithms were refined
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and tested further in an iterative, cyclical manner until no
further refinements were required.
Results
Sociodemographic and clinical details of participants taking
part in Phase 1 and 2 of the study are shown in Table 2.
Phase 1: symptom report development and ePRO system
integration into hospital EHR
Step 1: selection of relevant self-report items
Ninety-five items from 7 validated EORTC question-
naires were identified. Cognitive interviews with patients
(n = 18, 16 men, mean age 66 – Table 2) refined the long
list of items and confirmed the acceptability and feasibil-
ity of items. The final short list of 30 items to be in-
cluded in the developmental version of the ePRO
symptom-report questionnaire were taken from the fol-
lowing cancer-specific health-related quality of life
EORTC questionnaires: C30 (core cancer quality of life
module), OG25 (oesophago-gastric cancer module),
OES18 (oesophageal cancer module), LMC21 (colorectal
liver metastases module), and HCC18 (hepatocellular
carcinoma module). Consideration by clinical study team
members (JB, TR) resulted in 5 additional items not
already included in EORTC questionnaires being added
(e.g. wound problems), resulting in an ePRO symptom-re-
port comprising 35 items (Table 3).
Step 2: patient care pathway analysis
Analysis of patient care pathways identified that the
most appropriate time points for ePRO completion were
twice in the first week then weekly for 8 weeks post-dis-
charge. The most appropriate clinical contact for pa-
tients experiencing potential AEs was identified as the
cancer nurse specialist team.
Step 3: integration of the ePRO system into hospital electronic
health records
Multiple meetings were held with the study and IT team
at UHBT between February 2014 and January 2016 to
integrate the ePRO system into the UHBT hospital EHR
system (Medway). The integrated ePRO system was
launched in April 2016. Between April 2016 and August
2017 there were four instances of downtime/integration
loss totalling 145 days. This was due to an EHR software
update resulting in a loss of EHR integration and clini-
cians being unable to access ePRO results through the
EHR. A temporary workaround solution was developed
to allow researchers and clinicians to access ePRO re-
sults independently of EHR during periods of downtime.
This workaround required clinicians to access the ‘ad-
ministrator view’ of the live ePRO system hosted on a
secure server until an additional software update was is-
sued to resolve the issue.
Phase 2: development and testing of clinical algorithms
to guide patient management by symptom severity
Step 1: development of clinical algorithms
Of 300 patients screened, 130 (43%) patients were con-
sidered eligible and invited to participate, and 61 (47%)
patients consented (see Fig. 3). Of these, 59 (97%) partic-
ipants (34 men, mean age 61 years) accessed the ePRO
system a total of 459 times, resulting in 444 completed
self-reports. Two (3%) participants (1 man, mean age 72
years) did not complete the self-report at least once and
were excluded from subsequent analyses. Analysis of
Table 2 Baseline demographic and clinical characteristics of
participants
Phase 1: ePRO self-
report item selection
interviews (n = 18)
Phase 2: ePRO self-
report completion
participants (n = 61)
Sex, n (%)
Male 16 (89) 35 (57)
Female 2 (11) 26 (43)
Age, years
Mean (SD) 66.3 (6.7) 61.7 (12.6)
Range 53–80 27–81
Ethnicitya, n (%)
White British – 46 (75)
Mixed white Asian – 1 (2)
Not stated – 14 (23)
Cancer diagnosis, n (%)
Yes 18 (100) 47 (77)
No 0 14 (23)
Length of hospital staya, days
Mean (SD) – 12 (12)
Range – 2–64
Surgical procedure receivedb, n (%)
Oesophago-gastric resection 13 (72) 17 (28)
Hepatobiliary resection 5 (28) 44 (72)
Marital status, n (%)
Married/civil partnership 13 (72) 51 (84)
Single 3 (17) 3 (5)
Divorced 1 (5.5) 4 (6)
Widowed 1 (5.5) 3 (5)
Employment status, n (%)
Retired 12 (67) 32 (53)
Working full-time 4 (22) 18 (30)
Working part-time 1 (5.5) 4 (6)
Not in paid employment 1 (5.5) 7 (11)
SD standard deviation
aData not collected for item selection interview participants
bAll procedures performed with curative intent
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weekly follow-up interviews with these 59 participants
and additional end-of-study interviews with 7 partici-
pants (4 men, mean age 58 years, described above) indi-
cated a need for additional sub-items and branching
logic to make items more relevant to patients’ symptoms
and recovery. Specifically, 9 sub-items were added to
allow the ePRO self-report to distinguish between ‘typ-
ical’ symptoms (e.g. shortness of breath after physical ac-
tivity) and symptoms indicative of potential AEs (e.g.
shortness of breath at rest). Weekly telephone interviews
(n = 59 participants) also indicated that, for some items,
patients tended to report symptoms that were already
being appropriately managed or had resolved. To over-
come this retrospective reporting of managed or re-
solved symptoms, an additional sub-item was added to 8
items. This sub-item asked patients if the reported
symptom was a current issue, and the response incorpo-
rated into the clinical algorithm to trigger the appropri-
ate level of action by the ePRO system in order to guide
patient management appropriately.
Two stakeholder meetings (1 patient representative, 6
nurses, 2 dieticians and 1 surgeon from 4 hospital trusts)
indicated that, to account for natural improvements in
symptoms during recovery, length of time since hospital
Table 3 Final ePRO self-report items
ePRO self-report itemsa (n = 35)
1. Did you have any trouble taking a short walk outside of the house?b 19. Have you had itching?b
(a) Has this itching been due to another condition e.g. dry
skin, eczema or allergies?
2. Did you need to stay in bed or a chair during the day?b 20. Have you had fevers?b
(a) Is this a current issue?
3. Did you need help with eating, dressing, washing yourself or using the toilet?b 21. Have you had chills?b
(a) Is this a current issue?
4. Were you short of breath?b
(a) Have you been short of breath when just sitting down or resting?
22. Have you had pain?b
5. Have you had trouble sleeping?b 23. Did pain interfere with your daily activities?b
(a) Is this a current issue?
6. Have you felt nauseated?b
(a) Is your nausea or vomiting stopping you from drinking or eating?
24. Did you need to rest?b
7. Have you vomited?b
(a) Is your nausea or vomiting stopping you from drinking or eating?
25. Have you felt weak?b
8. Have you been constipated?b
(a) Are you passing wind?
26. Were you tired?b
9. Have you had diarrhoea?b
(a) Is this a current issue?
27. Have you lacked appetite?b
(a) Is this a current issue?
10. Have you had a dry mouth?b 28. Have you had problems eating solid foods?b
(a) Could you currently eat solid foods?
11. Have you had trouble with acid or bile coming into your mouth?b 29. Have you had problems eating liquidised or soft foods?b
(a) Could you currently eat liquidised or soft foods?
12. Have you had acid indigestion or heartburn?b 30. Have you had problems drinking liquids?b
(a) Could you currently able to drink liquids?
13. Have you had difficulty swallowing your saliva?b
(a) Have you been unable to swallow and had to spit out your saliva?
31. Have you had to have any sort of feeding tube fitted to
help with nutrition?c
14. Have you choked when swallowing?b
(a) Is this a current issue?
32. Has your surgical wound been red, warmer than the
surrounding skin, swollen or had any leaking fluid?b
(a) Is this a current issue?
15. Have you coughed?b
(a) Is this a current issue?
33. Has your surgical wound been painful to touch?b
16. Have you had abdominal swelling?b
(a) Are you passing wind?
34. Have you had any other side effects? (Please state)c
17. Have you had a sore mouth or tongue?b 35. Have you contacted any health professional regarding
any problems? (Please state)c
18. Have you been concerned by your skin or eyes being yellow (jaundiced)?b
(a) Is this a current issue?
aAll ePRO self-report items prefixed with ‘During the past week …’
bResponse options ‘Not at all’; ‘A little’; ‘Quite a bit’ and ‘Very much’
cResponse options ‘Yes’ or ‘No’
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discharge should be considered alongside symptom severity
in the development of the clinical algorithms. For example,
a high level of pain is expected at discharge but would be
concerning and potentially indicative of an AE if experi-
enced 6weeks later. The clinical algorithms were refined to
incorporate time since hospital discharge accordingly so
that threshold scores for relevant symptoms were altered
after 3 weeks post discharge to reflect the changes in symp-
toms experienced during typical recovery. Items included
in the final ePRO self-report questionnaire are detailed in
Table 3. Details of all changes made to the ePRO self-report
during its development are summarised in Table 4.
Step 2: development of patient self-management advice
Data from 15 routine care telephone consultations con-
ducted by a CNS with 8 participants (5 men, mean age
62 years) in the first week post-discharge were analysed.
Four main themes relating to post-operative advice and
reassurance sought by participants and/or provided by
the CNS were identified, including pain, other physical
symptoms, diet and nutrition and managing recovery
(Table 5). Findings from the end of study patient inter-
views (n = 7, 4 men, mean age 58 years) confirmed the
acceptability and relevance of self-management advice
and reassurance themes. These themes then formed the
Fig. 3 Phase 2 recruitment flow diagram. a including: n = 31 patients not undergoing planned procedure; n = 39 patients with no definitive cancer
diagnosis (prior to ethics amendment to enable inclusion of patients with no definitive diagnosis); n = 5 patients missed due to administration errors;
n = 1 patient who was under 18. b including: n = 35 patients not having home access to a PC/internet; n = 10 patients discharged home unexpectedly
early or not discharged to home; n = 3 patients not fluent in English; n = 2 patients unable to comply with follow up
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basis for developing the content of the self-management
advice.
A total of 28 PILs from 16 NHS Trusts and 3 cancer sup-
port charities (Macmillan Cancer Support, Oesophageal Pa-
tients Association, Oxfordshire Oesophageal and Stomach
Organisation) were sourced. Using methods of content ana-
lysis, these data were combined to produce first drafts of
patient self-management advice. These first drafts
were reviewed and revised according to input from
stakeholder meetings (6 nurses, 2 dieticians, 1 sur-
geon, 1 patient representative), resulting in the devel-
opment of self-management advice for 22 symptoms.
It was recognised through these iterative processes
that some symptom advice differed depending on type
of surgical procedure; this was made clear in the ad-
vice content to ensure patients followed the advice
relevant to their procedure.
Step 3: testing and refinement of clinical algorithms
Data previously generated from 27 participants’ (18
men, mean age 63 years) earlier in Phase 2 of the study
(described above) who reported clinically-significant
symptoms were reviewed and used to test and refine the
clinical algorithms. Comparisons were made between
sets of data (ePRO system actions and advice, clinician
telephone advice and clinical events/outcomes) from
these 27 patients, and any discrepancies identified and
discussed with the study team. Over an 8-month period,
refinements to the ePRO self-report questionnaire and
clinical algorithms were made (Table 3), including ad-
justments to the symptom severity thresholds triggering
ePRO system actions. Examples of final algorithm
thresholds for Level 1, 2 and 3 actions triggered by the
ePRO system are shown in Table 6.
Discussion
An electronic system for the routine capture of PRO
data has been developed to improve the detection and
management of complications after hospital discharge
following surgery. Unique features of the ePRO system
include its full integration into hospital EHR and the
function to apply clinical algorithms based on
Table 4 Summary of refinements made to ePRO symptom-report and clinical algorithms during ePRO system development
Iterative changes made to ePRO symptom-report
Area Issue identified Changes made
Selection of relevant
symptom-report items
Participants reported issues with comprehension
and interpretation of some items and response
categories.
Initial long list of 95 items from 7 validated EORTC
symptom-reports refined to 25 items in accordance
with patient interview data.
Selection of relevant
symptom-report items
Consultation with clinicians indicated that shortlist
of 25 symptom-report items did not cover all symptoms
patients are likely to experience following hospital
discharge.
Addition of five items, including items about wound
problems, feeding tubes, other side effects and any
contact with healthcare professionals.
Development of clinical
algorithms: Participant
symptom reporting
Patients could report ‘Very much’ for symptoms that
could generate Level 2 or Level 3 actions, but
weekly telephone follow-up interviews revealed that
symptoms were to be expected depending on context
(e.g. shortness of breath after physical activity
versus at rest)).
Addition of sub-items and two branching logic
questions if potentially concerning symptoms
reported:
(i) Branching question (“Is this a current issue?”)
added to 8 items to determine if reported symptom
is a current or resolved problem.
(ii) Branching question specific to symptom added
to 9 items to clarify severity (e.g. if patient reported
‘quite a bit’ or ‘very much’ shortness of breath, an
additional branching question asked, “Were you
short of breath while sitting down or resting?”.
Development of clinical
algorithms: Symptom severity
thresholds
Stakeholder meetings and discussion with clinicians
indicated that severity of some symptoms is expected
to vary during recovery (e.g. high levels of pain are
expected during week 1 post-discharge but would be
concerning at week 6.
Symptom severity thresholds were adapted for 11
items (e.g. pain, nausea & vomiting, appetite loss) to
account for expected variation during recovery
between weeks 3–8 post discharge. For example,
high levels of pain would generate a maximum of a
Level 2 action during weeks 1–2 post-discharge and
generate a Level 3 action in week 3.
Development of clinical
algorithms: Combined item
scoring
Patients responses to 1 of the 2 jaundice items
(itching) could generate an inappropriate jaundice
alert due to the combined scoring of these items,
even though itching may be due to allergies, dry
skin etc.
Following discussion with clinicians, the scoring for
itching and jaundice was split to prevent false
positive jaundice alerts. A branching question was
also added to the itching item to determine if this
was due to a known cause, such as an allergy or dry skin.
Development of patient
self-management advice
Patients reported uncertainty about whether their
symptoms were expected or concerning and found
this troubling.
Following analysis of telephone-based clinical
consultations, reassurance relating to expected
symptoms was identified and incorporated into
Level 1 patient self-management advice.
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patient-reported symptom-severity to guide the manage-
ment of patients, and automatically and instantly alert
clinicians of atypical symptoms. The ePRO system also
accounts for patient-level characteristics to provide
individually-tailored self-management advice necessary
to provide the wide range of support required by differ-
ent patients during their recovery at home [34], with pa-
tients able to use the system at any time they feel unwell
or want advice. In addition, the system is web-based for
easy and convenient access by patients using a home
computer or portable devices. Full evaluation is now
needed to examine its merits compared to standard care.
Until now, few ePRO systems have been developed
specifically to support patients after discharge from hos-
pital following surgery. Of 24 controlled trials identified
in a 2014 systematic review examining the effects of in-
cluding PROMs in routine clinical practice [20], only
two were relevant to surgical populations [19, 29]. Only
one of these was intended for post-discharge follow-up
(19). In this study, Cleeland et al. [19] described the use
of an ePRO system using interactive voice response
technology (as opposed to a web-based system) for trig-
gering clinician alerts to reduce post-operative symptom
severity after lung cancer surgery. It is noted that this
system did not provide patient self-management advice,
was not integrated within patients’ EHR and lacked pa-
tient input in the development of alert thresholds [19].
Similarly, Andikyan et al. [26] described evaluation of
the feasibility of a web-based ePRO (STAR) system for
assessing patient recovery up to 6 weeks after gynaecolo-
gic cancer surgery. The STAR questionnaire comprised
items from the patient-adaptation of the National
Cancer Institute (NCI) Common Terminology Criteria
for Adverse Events (CTCAE) and EORTC core
Table 5 Summary of advice and reassurance themes and subthemes identified from telephone-based clinical consultations
during recovery
Theme Sub-theme Clinician quotations
Pain Advice:
Pain management using prescribed
analgesics and activity levels
I would think of any medication as a tool there to help you get
through something.
Don’t be surprised if you find that you need them a little bit more
than others. If you’re going to do a little bit more then you might find
you’ll need to take them.
Reassurance:
Some level of pain is expected but can
be managed
Surgery can damage the nerve pathways and two weeks afterwards is
when they start to mend themselves, so that’s relatively classic that it’s
not there immediately after the operation but emerges afterwards.
Other physical symptoms Advice:
Practical advice relating to food choices,
changes in bowel function and ways to
manage these
Just give yourself enough breaks and rests
Keep in touch with the dietician, keep an eye on the symptoms. One
thing you need to keep in mind is that your stomach at the moment
is probably the smallest that it will be because it’s still quite swollen so
close to the operation.
Reassurance:
Distinction between expected
symptoms and concerning symptoms
and how to identify them
Shortness of breath is a representation of how hard you’re working. If
people get short of breath when they’re doing something – that’s part
of recovery. What we don’t want to see is someone sat in a chair and
having an episode of shortness of breath. But if it’s tied to you exerting
yourself that’s part of recovery and will improve with time.
Diet and nutrition Advice:
The initial approach needs to be flexible
and adaptive regarding portion size.
Certain food groups need to be
avoided
We want you to tailor our advice to suit you. If you want to eat in
stages, that’s perfectly reasonable. You’ll learn to know when you feel
full. You’ll learn to know when you’ve had enough and if you leave it
half an hour you can come back to it and enjoy round two.
Reassurance:
Appetite is likely to return and
adherence to advice about portion size
will improve this
This is about your appetite and you building it up as you want to and
getting you enjoying food again rather than looking at food as a
medicine.
Managing recovery Advice:
Practical advice about pacing physical
activities and setting goals
Our advice [for fatigue] would be ‘do a little, rest a little’ – and the
same for shortness of breath.
Try and be reasonable with your goals but have some goals so at the
end of the day you can say ‘yes, I did achieve that, I did make it to the
post box and back. A week ago, I was in hospital and now I’m able to
walk to the post box and back’
Reassurance:
Fatigue is expected. Recovery often
takes longer than expected and varies
day to day
It’s quite common for people to get that quite marked increase in
fatigue when they go home.
You’re going to have some really good days across those six months
and across that year, and there’ll be really good weeks when you think
‘Oh I’m back to normal’ – but then there’ll just be the odd day where
you think ‘I have been through a lot, I’m going to take it easy today.
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questionnaire (QLQ-C30) but was not integrated within
hospital EHR and symptom reports were provided to cli-
nicians only at the time of post-operative visits. Embed-
ding ePRO data capture within EHR may be
time-consuming and costly but previous research shows
that a lack of integration into standard systems is a key
barrier to clinicians’ uptake of electronic health systems
[35].
This study has several strengths. Multiple data sources,
including analyses of interviews and patient-clinician
consultations, have directly informed the selection and
refinement of ePRO self-report items, content of patient
self-management advice and development of the clinical
algorithms. The ePRO system has also been developed
in close collaboration with multiple key stakeholder
groups such as patients, patient representatives, nurses,
dieticians and surgeons. This approach has ensured that
the ePRO system actions are relevant and meaningful to
both patients and clinicians. In addition, the ePRO sys-
tem uses established, validated measures to assess pa-
tients’ HRQL, with the EORTC modules the most
frequently used PROMs in oncology studies.
This study does, however, have some limitations.
While patient participants with a broad range of socio-
demographic characteristics were included, the study
was conducted in a single centre in the example context
of cancer-related major abdominal surgery and it is pos-
sible that the characteristics of the sample do not typify
those of the wider population of patients undergoing
surgery. There is also a difference in the characteristics
of patients who participated in phase 1 and phase 2 of
the study, with more patients undergoing oesophago-
gastric surgery in phase 1 compared to more undergoing
hepatobiliary surgery in phase 2. Further work to de-
velop and test the system in a wider setting and in a
broader sample of patients is necessary to evaluate its
application as a useful adjunct to patient post-operative
care more generally. Depending on the surgical context,
the use of alternative disease-specific patient-reported
questionnaires may be considered to adapt the ePRO
system self-report and algorithms to other patient
groups. Integration of the ePRO system with the hospital
EPR was lost for a total of 145 days over the 17-month
study period due to an unsupported EHR software
Table 6 Examples of final algorithm thresholds for Level 1, Level 2 and Level 3 actions
ePRO self-report item question Item response Level generated
During the last week, were you short of breath?
Sub-item: If yes, have you been short of breath
when just sitting down or resting?
Not at all No feedback
A little, but not when resting No feedback
A little, and while at rest Level 2: Advice to contact HCP
Quite a bit, but not when resting Level 1 Self-management advice
Quite a bit, and while at rest Level 2 Advice to contact HCPa
Very much, but not when resting Level 2 Advice to contact HCPa
Very much, and while at rest Level 3 alert to HCPb
During the last week, has your surgical wound been
red, warmer that the surrounding skin, swollen or had
any leaking fluid?
Sub-item: If yes, if this a current issue?
Not at all No feedback
A little, but this is not a current issue No feedback
A little, and this is a current issue Level 2 Advice to contact HCPa
Quite a bit, but this is not a current issue Level 1 Self-management advice
Quite a bit, and this is a current issue Level 2 Advice to contact HCPa
Very much, but this is not a current issue Level 1 Self-management advice
Very much, and this is a current issue Level 3 alert to HCPb
During the last week, have you vomited?
Sub-item: If yes, is your vomiting stopping you from
drinking or eating?
Not at all No feedback
A little Level 1 Self-management advice
Quite a bit, but it has not stopped me from
eating or drinking
Level 2 Advice to contact HCPa
Quite a bit, and it has stopped me from eating
and drinking
Level 3 alert to HCPb
Very much, but it has not stopped me from
eating or drinking
Level 2 Advice to contact HCPa
Very much, and it has stopped me from eating
and drinking
Level 3 alert to HCPb
aLevel 2 advises patients to contact a health care professional today if their symptoms are new or unreported
bLevel 3 advises patients to contact a health care professional immediately. Additionally, an automated email alert is sent to the Cancer Nurse Specialist team
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update. While it was possible to implement a temporary
workaround, this incident highlights the potential impact
IT issues can have on the widespread use of ePRO sys-
tems within EHR and indicates that successful use in
routine clinical care would require full integration into
hospital EHR and ongoing maintenance by hospital IT
departments.
Surgery is associated with significant complications
and AEs, many of which occur after patients are dis-
charged home and require further clinical intervention.
Self-management of symptoms in the absence of ad-
equate medical knowledge to distinguish between ex-
pected and concerning symptoms can be worrying and
burdensome for patients and delay necessary treatment
[7–9]. An ePRO system with the functionality to apply
clinical algorithms to automatically alert clinicians in
real-time of atypical symptoms has the potential to im-
prove symptom control, patient safety and outcomes
and decrease emergency admissions, with the additional
potential of healthcare cost savings. Findings from a ran-
domised evaluation of the STAR ePRO system by Basch
et al. showed that the routine and real-time reporting of
PROs significantly reduces hospital readmissions and
improves patients’ survival and HRQL in cancer patients
compared to usual care, though this single centre trial
had several methodological weaknesses and limited gen-
eralisability [15]. Another RCT concluded that auto-
mated symptom monitoring via an interactive voice
response system and clinician alerts reduced symptom
severity in 100 patients during the month after lung can-
cer surgery compared to automated monitoring plus
usual care alone [19]. Symptoms were assessed using a
validated though generic cancer PROM. The study was
also small and conducted in a specialist tertiary care
centre, limiting its generalisability. It is also unclear how
patients were selected for inclusion in the study. Fur-
thermore, neither of these systems provided feedback or
advice to patients for symptom self-management or were
integrated in routine EHR.
Conclusions
Embedding prospectively-collected ePRO data into rou-
tine clinical practice has the potential to bring wider
benefits to patients and healthcare systems through stan-
dardising practice [13], streamlining and enhancing clin-
ical consultations [20, 25] and optimising personalised
and patient-centred care [24]. Data collected may also
be valuable to informing NHS policy and the develop-
ment of future treatments and services. Nevertheless,
standardised and routine ePRO data capture in patients
discharged from hospital after surgery is lacking. This
study describes the development of a real-time elec-
tronic symptom monitoring system for patients after dis-
charge following cancer-related surgery. A multicentre
prospective pilot study is ongoing to fully evaluate the
usability and acceptability of the ePRO system, including
data completeness, profiles of patient-reported symp-
toms and actions triggered, and patients’ and clinicians’
experiences of its usefulness. This pilot work will inform
a future RCT that will compare the effectiveness and
cost-effectiveness of the ePRO system versus usual care
for improving the detection of symptoms, complications
and patient outcomes after hospital discharge following
major elective surgery.
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